SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 107 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $161,000 | -22.2% | 36,093 | -5.0% | 0.07% | -16.5% |
| Q2 2021 | $207,000 | +7.3% | 37,977 | +47.4% | 0.08% | +3.7% |
| Q1 2021 | $193,000 | -29.8% | 25,773 | +1.8% | 0.08% | -28.1% |
| Q4 2020 | $275,000 | -10.7% | 25,323 | -27.3% | 0.11% | -29.6% |
| Q3 2020 | $308,000 | -27.0% | 34,835 | -12.0% | 0.16% | -19.0% |
| Q2 2020 | $422,000 | -0.5% | 39,578 | +11.2% | 0.20% | +354.5% |
| Q3 2018 | $424,000 | -32.7% | 35,601 | -42.3% | 0.04% | -92.1% |
| Q2 2018 | $630,000 | – | 61,719 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
| Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
| Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
| ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
| Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
| 683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
| EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
| ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
| Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |